XML 50 R32.htm IDEA: XBRL DOCUMENT v3.22.4
Common Stock and Stock-Based Incentive Compensation Plans (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Common Shares Outstanding Shares of common stock outstanding were as follows:
Year Ended
December 31,
2022
December 25,
2021
December 26,
2020
(In millions)
Balance, beginning of period1,207 1,211 1,170 
Common stock issued in the acquisition of Xilinx429 — — 
Common stock issued under employee equity plans17 12 14 
Repurchases of common stock(36)(17)— 
Common stock repurchases for tax withholding on equity awards(5)(2)(1)
Issuance of common stock to settle convertible debt— 3 28 
Balance, end of period1,612 1,207 1,211 
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs Stock-based compensation expense was allocated in the consolidated statements of operations as follows:
Year Ended
December 31, 2022December 25, 2021December 26, 2020
 (In millions)
Cost of sales$29 $5 $6 
Research and development697 246 173 
Marketing, general, and administrative355 128 95 
Total stock-based compensation expense before income taxes1,081 379 274 
Income tax benefit(179)(58)(42)
Total stock-based compensation expense, net of income taxes$902 $321 $232 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions The weighted-average estimated fair value of employee stock options granted during 2022, 2021 and 2020 was $44.35, $46.07 and $38.49 per share, respectively, using the following assumptions:
December 31, 2022December 25, 2021December 26, 2020
Expected volatility51.28 %51.77 %57.87 %
Risk-free interest rate3.00 %0.69 %0.18 %
Expected dividends— %— %— %
Expected life (in years)4.754.554.30
The weighted-average grant date fair values of PRSUs granted during 2022, 2021 and 2020 were $121.12, $153.89 and $122.95, respectively, using the following assumptions:
December 31, 2022December 25, 2021December 26, 2020
Expected volatility
50.65% - 53.51%
57.75 %
55.74% - 60.10%
Risk-free interest rate
1.14% - 3.17%
0.43 %
0.14% - 1.41%
Expected dividends— %— %— %
Expected term (in years)
2.07 - 3.07
3.00
2.48 - 3.00
Schedule of Share-based Compensation, Stock Options, Activity
The following table summarizes stock option activity and related information:
Outstanding Number
of Shares
Weighted-
Average
Exercise
Price
Aggregate Intrinsic ValueWeighted-Average Remaining Contractual Life
(in years)
 (In millions, except share price)
Balance as of December 25, 20215 $23.98 
Granted1 $95.54 
Exercised(2)$4.27 
Balance as of December 31, 20224 $42.35 $130 3.17
Exercisable December 31, 20223 $25.67 $130 2.27
Schedule of Share-based Compensation, Restricted Stock Units, Activity
The following table summarizes time-based RSU activity and related information:
Number
of Shares
Weighted- Average Grant Date Fair ValueAggregate Intrinsic ValueWeighted-Average Remaining Contractual Life
(in years)
 (In millions except share price)
Unvested shares as of December 25, 202110 $79.03 
Assumed with acquisition of Xilinx12 $103.35 
Granted17 $92.92 
Forfeited(2)$98.06 
Vested(9)$86.27 
Unvested shares as of December 31, 202228 $95.49 $1,810 1.67
Schedule of Nonvested Performance-based Units Activity
The following table summarizes PRSU activity and related information:
 Number
of Shares
Weighted-Average
Grant Date Fair Value
Aggregate Intrinsic ValueWeighted-Average Remaining Contractual Life
(in years)
(In millions except share price)
Unvested shares as of December 25, 20212 $78.59 
Granted1 $121.12 
Forfeited— $— 
Vested(1)$51.77 
Unvested shares as of December 31, 20222 $110.31 $118 1.76
Schedule of ESPP The weighted-average grant date fair value for the ESPP during 2022, 2021 and 2020 was $24.71, $27.27 and $20.97 per share, respectively, using the following assumptions:
December 31, 2022December 25, 2021December 28, 2020
Expected volatility
58.15% - 63.76%
36.90% - 39.39%
55.16% - 66.53%
Risk-free interest rate
1.43% - 4.52%
0.04% - 0.07%
0.11% - 0.15%
Expected dividends— %— %— %
Expected term (in years)0.500.500.50